Biologics and Biosimilar Regulations and Registration in South Korea
The Korean pharmaceutical market is estimated to be worth $24.3 billion in 2019, and between 2015 and 2019, it grew at a compound annual...
top of page
Search
- Sep 1
- 7 min
Biologics and Biosimilars Regulation and Registration in India (CDSCO)
The size of the Indian biosimilars market, which was anticipated to be worth $349 million in 2022, is expected to increase to $2108...
- Aug 31
- 5 min
Biologics and Biosimilar Regulation and Registration in Japan (PMDA)
With the exception of the United States, Japan's biosimilar business, with a market value of $140 million, accounted for just 5% of the...
- Aug 28
- 5 min
Biologics and Biosimilar Regulations and Registration in the European Union (EU) (EMA)
In 2022, the Europe biosimilar market had a value of almost USD 4601.56 million. In addition, it is anticipated that the biosimilar...
- Aug 23
- 5 min
Biologics and Biosimilars Regulations and Registration in Mexico (COFEPRIS)
Mexico is the second-largest drug market in Latin America, after Brazil. With a compound annual growth rate (CAGR) of 38.7%, the Mexican...
- Aug 18
- 4 min
Biologics and Biosimilars Regulations and Registration in China (NMPA)
This article outlines Biologics and Biosimilars Regulations and Registration process in China (NMPA). In China, 40% of the biologics...
- Aug 17
- 5 min
Biologics and Biosimilar Regulations and Registration in Brazil
According to the Drugs Sector Regulation Chamber (CMED) in 2022, the Brazilian pharmaceutical sector generated US $17.2 billion in sales...
- Aug 9
- 5 min
Biologics and Biosimilars Regulations, Registration Process in the USA (FDA)
The size of the U.S. biosimilars market, estimated at USD 6.73 billion in 2021, is expected to increase by USD 9.48 billion in 2022 and...
bottom of page